Literature DB >> 29559302

Myo/Nog cells are present in the ciliary processes, on the zonule of Zinn and posterior capsule of the lens following cataract surgery.

Jacquelyn Gerhart1, Colleen Withers1, Colby Gerhart1, Liliana Werner2, Nick Mamalis2, Arturo Bravo-Nuevo1, Victoria Scheinfeld1, Paul FitzGerald3, Robert Getts4, Mindy George-Weinstein5.   

Abstract

Myo/Nog cells, named for their expression of MyoD and noggin, enter the eye during early stages of embryonic development. Their release of noggin is critical for normal morphogenesis of the lens and retina. Myo/Nog cells are also present in adult eyes. Single nucleated skeletal muscle cells designated as myofibroblasts arise from Myo/Nog cells in cultures of lens tissue. In this report we document the presence of Myo/Nog cells in the lens, ciliary body and on the zonule of Zinn in mice, rabbits and humans. Myo/Nog cells were rare in all three structures. Their prevalence increased in the lens and ciliary body of rabbits 24 h following cataract surgery. Rabbits developed posterior capsule opacification (PCO) within one month of surgery. The number of Myo/Nog cells continued to be elevated in the lens and ciliary body. Myo/Nog cells containing alpha smooth muscle actin and striated muscle myosin were present on the posterior capsule and overlaid deformations in the capsule. Myo/Nog cells also were present on the zonule fibers and external surface of the posterior capsule. These findings suggest that Myo/Nog contribute to PCO and may use the zonule fibers to migrate between the ciliary processes and lens.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ciliary body; Lens; Myo/Nog cells; Posterior capsule opacification; Zonule

Mesh:

Substances:

Year:  2018        PMID: 29559302      PMCID: PMC6085112          DOI: 10.1016/j.exer.2018.03.016

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  34 in total

1.  Determinants of nuclear and cytoplasmic ubiquitin-mediated degradation of MyoD.

Authors:  Jody M Lingbeck; Julie S Trausch-Azar; Aaron Ciechanover; Alan L Schwartz
Journal:  J Biol Chem       Date:  2002-10-22       Impact factor: 5.157

2.  NeuroM and MyoD are expressed in separate subpopulations of cells in the pregastrulating epiblast.

Authors:  Robert Strony; Jacquelyn Gerhart; Dolores Tornambe; Jordanna Perlman; Christine Neely; Jeffrey Dare; Benjamin Stewart; Mindy George-Weinstein
Journal:  Gene Expr Patterns       Date:  2005-02       Impact factor: 1.224

3.  Ciliary Body and Ciliary Epithelium.

Authors:  Nicholas A Delamere
Journal:  Adv Organ Biol       Date:  2005-01-01

4.  Antibody-Conjugated, DNA-Based Nanocarriers Intercalated with Doxorubicin Eliminate Myofibroblasts in Explants of Human Lens Tissue.

Authors:  Jacquelyn Gerhart; Marvin Greenbaum; Lou Casta; Anthony Clemente; Keith Mathers; Robert Getts; Mindy George-Weinstein
Journal:  J Pharmacol Exp Ther       Date:  2017-01-17       Impact factor: 4.030

5.  Reversible differentiation of myofibroblasts by MyoD.

Authors:  Louise Hecker; Rajesh Jagirdar; Toni Jin; Victor J Thannickal
Journal:  Exp Cell Res       Date:  2011-04-01       Impact factor: 3.905

6.  Skeletal myogenesis: the preferred pathway of chick embryo epiblast cells in vitro.

Authors:  M George-Weinstein; J Gerhart; R Reed; J Flynn; B Callihan; M Mattiacci; C Miehle; G Foti; J W Lash; H Weintraub
Journal:  Dev Biol       Date:  1996-01-10       Impact factor: 3.582

7.  Disruption of murine Adamtsl4 results in zonular fiber detachment from the lens and in retinal pigment epithelium dedifferentiation.

Authors:  Gayle B Collin; Dirk Hubmacher; Jeremy R Charette; Wanda L Hicks; Lisa Stone; Minzhong Yu; Jürgen K Naggert; Mark P Krebs; Neal S Peachey; Suneel S Apte; Patsy M Nishina
Journal:  Hum Mol Genet       Date:  2015-09-24       Impact factor: 6.150

8.  Sarcomeric gene expression and contractility in myofibroblasts.

Authors:  D C Mayer; L A Leinwand
Journal:  J Cell Biol       Date:  1997-12-15       Impact factor: 10.539

9.  MyoD-positive myoblasts are present in mature fetal organs lacking skeletal muscle.

Authors:  J Gerhart; B Bast; C Neely; S Iem; P Amegbe; R Niewenhuis; S Miklasz; P F Cheng; M George-Weinstein
Journal:  J Cell Biol       Date:  2001-10-29       Impact factor: 10.539

10.  Cells that express MyoD mRNA in the epiblast are stably committed to the skeletal muscle lineage.

Authors:  Jacquelyn Gerhart; Christine Neely; Justin Elder; Jessica Pfautz; Jordanna Perlman; Luis Narciso; Kersti K Linask; Karen Knudsen; Mindy George-Weinstein
Journal:  J Cell Biol       Date:  2007-08-13       Impact factor: 10.539

View more
  4 in total

1.  Mutation of the TRPM3 cation channel underlies progressive cataract development and lens calcification associated with pro-fibrotic and immune cell responses.

Authors:  Yuefang Zhou; Thomas M Bennett; Alan Shiels
Journal:  FASEB J       Date:  2021-02       Impact factor: 5.834

2.  Brain-specific angiogenesis inhibitor 1 is expressed in the Myo/Nog cell lineage.

Authors:  Jacquelyn Gerhart; Jessica Bowers; Lindsay Gugerty; Colby Gerhart; Mark Martin; Fathma Abdalla; Arturo Bravo-Nuevo; Jonathan Tabb Sullivan; Rebecca Rimkunas; Amie Albertus; Lou Casta; Lori Getts; Robert Getts; Mindy George-Weinstein
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

Review 3.  Factors Affecting Posterior Capsule Opacification in the Development of Intraocular Lens Materials.

Authors:  Grace Cooksley; Joseph Lacey; Marcus K Dymond; Susan Sandeman
Journal:  Pharmaceutics       Date:  2021-06-10       Impact factor: 6.321

4.  Acute Response and Neuroprotective Role of Myo/Nog Cells Assessed in a Rat Model of Focal Brain Injury.

Authors:  Sahlia Joseph-Pauline; Nathan Morrison; Michael Braccia; Alana Payne; Lindsay Gugerty; Jesse Mostoller; Paul Lecker; E-Jine Tsai; Jessica Kim; Mark Martin; Rushil Brahmbhatt; Grzegorz Gorski; Jacquelyn Gerhart; Mindy George-Weinstein; Jonathan Stone; Sivaraman Purushothuman; Arturo Bravo-Nuevo
Journal:  Front Neurosci       Date:  2021-12-07       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.